Ann Lab Med.  2020 May;40(3):232-237. 10.3343/alm.2020.40.3.232.

Genetic Counseling Status and Perspectives Based on a 2018 Professional Survey in Korea

Affiliations
  • 1Department of Laboratory Medicine, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Korea.
  • 2Department of Cancer Biomedical Science, National Cancer Center Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea.
  • 3Department of Laboratory Medicine, National Cancer Center, Goyang, Korea.
  • 4BioCore Co. Ltd., Division of Biotechnology, Yongin, Korea.
  • 5Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • 6Department of Laboratory Medicine, Daegu Catholic Medical Center, Daegu, Korea.
  • 7Department of Laboratory Medicine, National Health Insurance Service, Ilsan Hospital, Goyang, Korea. jhyooken@gmail.com

Abstract

BACKGROUND
Genetic counseling (GC) provides many benefits, including the identification of patients appropriate for testing, patient education, and medical management. We evaluated the current status of and challenges faced by GC practitioners in Korean hospitals.
METHODS
An electronic survey was designed and conducted in 52 certified laboratory physicians belonging to the Korean Society of Laboratory Medicine, from August to September 2018. The questionnaires addressed three main categories of information: (1) current status of GC in hospitals; (2) essential qualifications of GC practitioners; and (3) challenges and perspectives for GC. Fisher's exact test was applied to analyze categorical data.
RESULTS
Among a total of 52 participants who initially responded, 12 (23.1%) were performing GC either by direct or indirect care. GC clinics were opened regularly for one (33.3%) or more than three sessions (25.0%) per week; most respondents spent more time for pre-visit activities than in-person visits, both for a initial visit patient and for a follow-up visit patient. All laboratory physicians provided genetic information to their patients. Most recommended family genetic testing when indicated (91.7%), discussed disease management (75.0%), and/or ordered additional genetic testing (58.3%), and some referred patients to other specialists (8.3%).
CONCLUSIONS
Both patients and laboratory physicians concede the advantage of GC performed by clinical geneticists; however, the practice of GC involves several challenges and raises some concerns. The cost and support required to implement GC need to be addressed in order to provide qualified GC in Korea.

Keyword

Genetic counseling; Genetic testing; Laboratory physician; Survey

MeSH Terms

Disease Management
Follow-Up Studies
Genetic Counseling*
Genetic Testing
Humans
Korea*
Patient Education as Topic
Specialization
Surveys and Questionnaires

Cited by  1 articles

Current Issues, Challenges, and Future Perspectives of Genetic Counseling in Korea
Namhee Kim, Sun-Young Kong, Jongha Yoo, Do-Hoon Kim, Soo Hyun Seo, Jieun Kim
Ann Lab Med. 2022;42(3):314-320.    doi: 10.3343/alm.2022.42.3.314.


Reference

1. Leopold JA, Loscalzo J. Emerging role of precision medicine in cardiovascular disease. Circ Res. 2018; 122:1302–1315. PMID: 29700074.
2. Lee S, Choi M. Ultra-rare disease and genomics-driven precision medicine. Genomics Inform. 2016; 14:42–45. PMID: 27445646.
3. Sohn J. Next generation sequencing and anti-cancer therapy. J Korean Med Assoc. 2019; 62:119–129.
4. Balmaña J, Sanz J, Bonfill X, Casado A, Rué M, Gich I, et al. Genetic counseling program in familial breast cancer: analysis of its effectiveness, cost and cost-effectiveness ratio. Int J Cancer. 2004; 112:647–652. PMID: 15382046.
5. Greeley SAW, John PM, Winn AN, Ornelas J, Lipton RB, Philipson LH, et al. The cost-effectiveness of personalized genetic medicine: the case of genetic testing in neonatal diabetes. Diabetes Care. 2011; 34:622–627. PMID: 21273495.
6. Lawrence WF, Peshkin BN, Liang W, Isaacs C, Lerman C, Mandelblatt JS. Cost of genetic counseling and testing for BRCA1 and BRCA2 breast cancer susceptibility mutations. Cancer Epidemiol Biomarkers Prev. 2001; 10:475–481. PMID: 11352857.
7. Arora NS, Davis JK, Kirby C, McGuire AL, Green RC, Blumenthal-Barby JS, et al. Communication challenges for nongeneticist physicians relaying clinical genomic results. Per Med. 2016; 14:423–431. PMID: 29181085.
8. Kim HJ. Genetic counseling in Korean health care system. J Genet Med. 2011; 8:89–99.
9. Mikat-Stevens NA, Larson IA, Tarini BA. Primary-care providers’ perceived barriers to integration of genetics services: a systematic review of the literature. Genet Med. 2015; 17:169–176. PMID: 25210938.
10. Lee YW, Ki CS, Shin HB, Choi TY, Kim JW, Kim SH, et al. Establishment and management of medical genetic clinic based on genetic testing network. Korean J Lab Med. 2006; 26:137–141. PMID: 18156715.
11. Nelson HD, Pappas M, Zakher B, Mitchell JP, Okinaka-Hu L, Fu R. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation. Ann Intern Med. 2014; 160:255–266. PMID: 24366442.
12. Laurino MY, Leppig KA, Abad PJ, Cham B, Chu YWY, Kejriwal S, et al. A report on ten Asia Pacific countries on current status and future directions of the genetic counseling profession: the establishment of the Professional Society of Genetic Counselors in Asia. J Genet Couns. 2018; 27:21–32. PMID: 28699126.
13. Hoskovec JM, Bennett RL, Carey ME, DaVanzo JE, Dougherty M, Hahn SE, et al. Projecting the supply and demand for certified genetic counselors: a workforce study. J Genet Couns. 2018; 27:16–20. PMID: 29052810.
14. Kausmeyer DT, Lengerich EJ, Kluhsman BC, Morrone D, Harper GR, Baker MJ. A survey of patients’ experiences with the cancer genetic counseling process: recommendations for cancer genetics programs. J Genet Couns. 2006; 15:409–431. PMID: 17106634.
15. Lee CH, Lim H, Kim Y, Yoon S, Park YS, Kim SA, et al. Analysis of new patient’s willingness to pay additional costs for securing satisfactory consultation time. Health Policy Manag. 2017; 27:39–46.
16. McPherson E, Zaleski C, Benishek K, McCarty CA, Giampietro PF, Reynolds K, et al. Clinical genetics provider real-time workflow study. Genet Med. 2008; 10:699–706. PMID: 18978682.
17. Heald B, Rybicki L, Clements D, Marquard J, Mester J, Noss R, et al. Assessment of clinical workload for general and specialty genetic counsellors at an academic medical center: a tool for evaluating genetic counselling practices. NPJ Genom Med. 2016; 1:16010. PMID: 29263811.
18. National Society of Genetic Counselors' Definition Task Force. Resta R, Biesecker BB, Bennett RL, Blum S, Hahn SE, et al. A new definition of genetic counseling: National Society of Genetic Counselors' task force report. J Genet Couns. 2006; 15:77–83. PMID: 16761103.
19. Ormond KE, Laurino MY, Barlow-Stewart K, Wessels TM, Macaulay S, Austin J, et al. Genetic counseling globally: where are we now? Am J Med Genet C Semin Med Genet. 2018; 178:98–107. PMID: 29575600.
20. Zatz M, Passos-Bueno MR, Vainzof M. Neuromuscular disorders: genes, genetic counseling and therapeutic trials. Genet Mol Biol. 2016; 39:339–348. PMID: 27575431.
21. Caso R, Beamer M, Lofthus AD, Sosin M. Integrating surgery and genetic testing for the modern surgeon. Ann Transl Med. 2017; 5:399. PMID: 29152499.
22. Lehr HA, Bosman FT. Communication skills in diagnostic pathology. Virchows Arch. 2016; 468:61–67. PMID: 26481246.
23. Agnese DM, Pollock RE. Breast cancer genetic counseling: a surgeon's perspective. Front Surg. 2016; 3:4. PMID: 26858951.
Full Text Links
  • ALM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr